In vitro susceptibility test of different clinical isolates against ceftriaxone

Oman Medical Journal

Volumn 25, Issue 3, 2010, Pages 199-202

  Masood, Syed Hakim ^a   Aslam, Nousheen ^b,c  

^a Minsitry of Health   (Pakistan)

^b ZIAUDDIN UNIVERSITY   (Pakistan)

^c UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CEPHALOSPORIN;

AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; DISK DIFFUSION; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR TYPHI; STAPHYLOCOCCUS AUREUS; ZONE OF INHIBITION;

EID: 83055196505     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2010.56     Document Type: Article

References (29)

1. Nath SK, Foster GA, Mandell LA, Rotstein C. Antimicrobial activity of ceftriaxone versus cefotaxime: negative effect of serum albumin binding of ceftriaxone. J Antimicrob Chemother 1994 Jun;33(6):1239-1243.
2. Masood H, Naqvi SB, Aslam N. Cost effective analysis of different brands of ceftriaxone available in Karachi Pakistan. Pak J Pharmacol 2008;25:13-19.
3. Hwang KP, Tang YF, Shen YH. Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia. J Microbiol Immunol Infect 2009 Oct;42(5):433-438.
4. Supp DM, Gardner J, Klingenberg JM, Neely AN. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4. Burns 2009 Nov;35(7):949-955. Published online 6 Jun 2009.
5. Liaqat I, Sumbal F, Sabri AN. Tetracycline and chloramphenicol efficiency against selected biofilm forming bacteria. Curr Microbiol 2009 Aug;59(2):212-220.
6. Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN; Sentry APAC Study Group. Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002 Mar;42(3):193-198.
7. Khan S, Gupta DK, Khan DN. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis. Kathmandu Univ Med J (KUMJ) 2005 Jan-Mar;3(1):55-63.
8. Huang TM, Lin TL, Wu CC. Antimicrobial susceptibility and resistance of chicken Escherichia coli, Salmonella spp., and Pasteurella multocida isolates. Avian Dis 2009 Mar;53(1):89-93.
9. Khameneh ZR, Afshar AT. Antimicrobial susceptibility pattern of urinary tract pathogens. Saudi J Kidney Dis Transpl 2009 Mar;20(2):251-253.
10. Irfan S, Idrees F, Mehraj V, Habib F, Adil S, Hasan R. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis 2008;8:80.
11. Zarakolu P, Sakizligil B, Unal S. [Antimicrobial resistance of Neisseria gonorrhoeae strains isolated from sex workers in Ankara]. Mikrobiyol Bul 2006 Jan-Apr;40(1-2):69-73.
12. King A, Bethune L, Phillips I. In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria. Antimicrob Agents Chemother 1993 Apr;37(4):746-749.
13. Madhulika U, Harish BN, Parija SC. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry. Indian J Med Res 2004 Aug;120(2):111-114.
14. Francioli P, Etienne J, Hoigné R, Thys JP, Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 1992 Jan;267(2):264-267.
15. Mamishi S, Pourakbari B, Ashtiani MH, Hashemi FB. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children’s Medical Center, Tehran, Iran, 1996-2000. Int J Antimicrob Agents 2005 Nov;26(5):373-379.
16. Dunne EF, Fey PD, Kludt P, Reporter R, Mostashari F, Shillam P, et al. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. JAMA 2000 Dec;284(24):3151-3156.
17. Hsueh PR, Chen WH, Luh KT. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005 Dec;26(6):463-472.
18. Karlowsky A, Jones ME, Mayfield DC, Thornsberry C, Sahm DF. Ceftriaxone activity against Gram-positive and Gram-negative bacteria isolated in US clinical microbiology laboratories from 1996 to 2000: results from The Surveillance Network Database-USA International Journal of Antimicrobial Agents 2002;19 (5): 2002, 413-426.
19. Lee SC, Huang SS, Lee CW, Fung CP, Lee N, Shieh WB, et al. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan. BMC Infect Dis 2007;7:79.
20. Boyanova L, Kolarov R, Gergova G, Deliverska E, Madjarov J, Marinov M, et al. Anaerobic bacteria in 118 patients with deep-space head and neck infections from the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria. J Med Microbiol 2006 Sep;55(9):1285-1289.
21. George AK., Archiva SWl, Catherine, Monserrat, Carlyn C. Use of the National Committee for Clinical Laboratory Standards Guide Lies for Disk Diffusion Susceptibility Testing in New York State Laboratories. J Clin Microbiol 2000;38(9):3348.
22. Shoaib MH. Naqvi SB, Shiekh D, Hashmi HK. Cephalosporin Resistance And B-Lactamase Production In Clinical Isolates Of Staphylococcus Aureus In Karachi. Pak J Pharm Sci 2001;14(2):23-32.
23. Vogt RL, Dippold L. Escherichia coli O157:H7 outbreak associated with consumption of ground beef, June-July 2002. Public Health Rep 2005 Mar-Apr;120(2):174-178.
24. Abdul Jalil, Shafiq Ahmad Tariq, Iftikhar Ud Din Niazi. Comparative susceptibilities of Escherichia coli to ceftriaxone alone and in combination with clavulanic acid. J. Med. Sci. (Peshawar, Print) January 2009, Vol. 17, No. 1: 12-15.
25. Fleiszig SM, Evans DJ. The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa. Clin Exp Optom 2002 Sep;85(5):271-278.
26. Irfan S, Idrees F, Mehraj V, Habib F, Adil S, Hasan R. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis 2008;8:80.
27. Farooqi BJ, Shareeq F, Rizvi QK, Qureshi HS, Ashfaq MK. Changing pattern of antimicrobial susceptibility of organisms causing community acquired urinary tract infections. J Pak Med Assoc 2000 Nov;50(11):369-373.
28. Naeem I, Naqvi BS, Hashmi K, Gauhar S. Paediatric nosocomial infections: resistance pattern of clinical isolates. Pak J Pharm Sci 2006 Jan;19(1):52-57.
29. Iqbal SM, Udaipurwala IH, Shafiq AH, Mughal S. Chronic suppurative otitis media: disease pattern and drug sensitivity. J Surg Pak 2006;11(1):17-19.